Statements (43)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:administered_by |
oral route
|
| gptkbp:administration_age |
administered to infants
|
| gptkbp:associated_with |
gptkb:virus
|
| gptkbp:availability |
widely available in developing countries
|
| gptkbp:clinical_trial |
extensively tested in clinical trials
|
| gptkbp:community_acceptance |
high community acceptance in many regions
|
| gptkbp:community_health |
significantly reduced polio cases
|
| gptkbp:contraindication |
immunocompromised individuals
|
| gptkbp:developed_by |
gptkb:Albert_Bruce_Sabin
|
| gptkbp:dose_schedule |
multiple doses required
|
| gptkbp:first_introduced |
gptkb:Soviet_Union
|
| gptkbp:formulation |
drops
|
| gptkbp:global_presence |
used in over 100 countries
|
| gptkbp:history |
developed in the 1950s
|
| https://www.w3.org/2000/01/rdf-schema#label |
oral polio vaccine (OPV)
|
| gptkbp:immunization_strategy |
part of global polio eradication initiative
|
| gptkbp:introduced_in |
gptkb:1961
|
| gptkbp:is_effective_against |
high efficacy in preventing polio
|
| gptkbp:is_recommended_by |
gptkb:World_Health_Organization
|
| gptkbp:is_vulnerable_to |
oral polio vaccine
high coverage in immunization programs some vaccine hesitancy reported |
| gptkbp:manufacturer |
various pharmaceutical companies
|
| gptkbp:mechanism_of_action |
induces intestinal immunity
|
| gptkbp:part_of |
expanded program on immunization (EPI)
|
| gptkbp:price |
low-cost vaccine
|
| gptkbp:provides_immunity |
long-term immunity
|
| gptkbp:public_perception |
generally positive perception
|
| gptkbp:regulatory_compliance |
approved by health authorities
|
| gptkbp:replaced_by |
inactivated polio vaccine (IPV) in some countries
|
| gptkbp:research_focus |
ongoing research for improved formulations
|
| gptkbp:safety_features |
generally safe
|
| gptkbp:side_effect |
mild gastrointestinal symptoms
|
| gptkbp:storage |
refrigeration not required
|
| gptkbp:success_rate |
high success rate in outbreak control
|
| gptkbp:supply_chain |
requires cold chain for distribution
|
| gptkbp:targets |
gptkb:poliomyelitis
|
| gptkbp:type |
live attenuated vaccine
|
| gptkbp:used_in |
mass immunization campaigns
|
| gptkbp:bfsParent |
gptkb:first_effective_polio_vaccine
gptkb:inactivated_polio_vaccine_(IPV) |
| gptkbp:bfsLayer |
7
|